Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The ‘Haves And Have-Nots’ Are Becoming Clearer In Cell And Gene Therapy

16 Jan 2024

• By Andrew McConaghie

Related Companies

Sarepta Therapeutics, Inc.

Vertex Pharmaceuticals Incorporated

CRISPR Therapeutics AG

Bluebird Bio

Novartis AG

Kyowa Kirin Co., Ltd.

Pfizer Inc.

AstraZeneca PLC

Krystal Biotech, Inc.

Rocket Pharmaceuticals Inc.

BioMarin Pharmaceutical Inc.

Roche Holding AG

Taysha Gene Therapies, Inc.

Lysogene SA

Intergalactic Therapeutics

Locanabio, Inc.

Gyroscope Therapeutics Limited

Orchard Therapeutics Limited

Additional Topics

Gene Therapy Regenerative Medicine Commercial Research & Development Pricing Debate Rare Diseases StartUps and SMEs Evaluate Data Oncology BioPharmaceutical

More from Gene Therapies

More from Advanced Therapies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.